AdvaMed Delegates Go To China; Business Ethics Code In The Works
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed and Chinese device makers agreed to harmonize China's standards for ethical business practices with AdvaMed's code of ethics and other international policies in a memorandum of understanding signed earlier this month
You may also be interested in...
Imaging Industry Expands Emerging Market Focus
A recent award from the U.S. Commerce Department comes at an opportune time for the imaging and radiation therapy industry to accelerate its push for regulatory reforms in China and India, says the sector’s top lobbyist.
Imaging Industry Expands Emerging Market Focus
A recent award from the U.S. Commerce Department comes at an opportune time for the imaging and radiation therapy industry to accelerate its push for regulatory reforms in China and India, says the sector’s top lobbyist.
Asia-Pacific device ethics code
Asia-Pacific Economic Cooperation forum, which aims to facilitate economic growth and cooperation in the Asia-Pacific region, announces efforts to develop a code of business ethics for the medical device sector in the area. The effort stems from a recent APEC workshop on device sector business ethics, held in Japan. Trade group AdvaMed endorses the efforts in an Oct. 8 statement, saying that device firms looking to grow in the Asia-Pacific region currently are "faced with the lack of consistent, predictable and transparent legal and regulatory frameworks in the area of business ethics." The code in development "is an important step forward in our mission to harmonize business ethics globally," said AdvaMed Chairman and Abbott Medical Optics President James Mazzo. AdvaMed and Chinese device makers agreed to harmonize their codes of ethics in September (1"The Gray Sheet" Sept. 20, 2010)